155 related articles for article (PubMed ID: 17632078)
1. Platelet-rich plasma stimulates osteoblastic differentiation in the presence of BMPs.
Tomoyasu A; Higashio K; Kanomata K; Goto M; Kodaira K; Serizawa H; Suda T; Nakamura A; Nojima J; Fukuda T; Katagiri T
Biochem Biophys Res Commun; 2007 Sep; 361(1):62-7. PubMed ID: 17632078
[TBL] [Abstract][Full Text] [Related]
2. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2.
Gutierrez J; Osses N; Brandan E
J Cell Physiol; 2006 Jan; 206(1):58-67. PubMed ID: 15920756
[TBL] [Abstract][Full Text] [Related]
3. Osteogenic differentiation induced by bone morphogenetic proteins can be suppressed by platelet-released supernatant in vitro.
Gruber R; Kandler B; Fischer MB; Watzek G
Clin Oral Implants Res; 2006 Apr; 17(2):188-93. PubMed ID: 16584415
[TBL] [Abstract][Full Text] [Related]
4. Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. An in vitro study.
Arpornmaeklong P; Kochel M; Depprich R; Kübler NR; Würzler KK
Int J Oral Maxillofac Surg; 2004 Jan; 33(1):60-70. PubMed ID: 14690661
[TBL] [Abstract][Full Text] [Related]
5. Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances osteoblast differentiation.
Miyazaki T; Miyauchi S; Tawada A; Anada T; Matsuzaka S; Suzuki O
J Cell Physiol; 2008 Dec; 217(3):769-77. PubMed ID: 18720384
[TBL] [Abstract][Full Text] [Related]
6. Platelet-rich plasma/osteoblasts complex induces bone formation via osteoblastic differentiation following subcutaneous transplantation.
Goto H; Matsuyama T; Miyamoto M; Yonamine Y; Izumi Y
J Periodontal Res; 2006 Oct; 41(5):455-62. PubMed ID: 16953822
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha inhibits BMP-induced osteoblast differentiation through activating SAPK/JNK signaling.
Mukai T; Otsuka F; Otani H; Yamashita M; Takasugi K; Inagaki K; Yamamura M; Makino H
Biochem Biophys Res Commun; 2007 May; 356(4):1004-10. PubMed ID: 17397798
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation.
Nakagawa K; Imai Y; Ohta Y; Takaoka K
Bone; 2007 Oct; 41(4):543-8. PubMed ID: 17681894
[TBL] [Abstract][Full Text] [Related]
9. Relationship of bone morphogenetic protein expression during osteoblast differentiation to wild type p53.
Chandar N; Swindle J; Szajkovics A; Kolman K
J Orthop Res; 2005 Nov; 23(6):1345-53. PubMed ID: 15994055
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone modulates BMP-2 effects on mesenchymal stem cells in vitro.
Jäger M; Fischer J; Dohrn W; Li X; Ayers DC; Czibere A; Prall WC; Lensing-Höhn S; Krauspe R
J Orthop Res; 2008 Nov; 26(11):1440-8. PubMed ID: 18404732
[TBL] [Abstract][Full Text] [Related]
11. Effects of bone morphogenetic protein on neonatal rat calvarial osteoblast-like cells: an in vitro study.
Aybar B; Emes Y; Atalay B; Vural P; Kaya AS; Eren SN; Işsever H; Bilir A
J Biomed Mater Res A; 2008 Aug; 86(2):560-8. PubMed ID: 18260142
[TBL] [Abstract][Full Text] [Related]
12. Purification and identification of a BMP-like factor from bovine serum.
Kodaira K; Imada M; Goto M; Tomoyasu A; Fukuda T; Kamijo R; Suda T; Higashio K; Katagiri T
Biochem Biophys Res Commun; 2006 Jul; 345(3):1224-31. PubMed ID: 16716261
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis induction and reduced proliferation in human osteoblasts by rhBMP-2, -4 and -7.
Gautschi OP; Cadosch D; Zellweger R; Joesbury KA; Filgueira L
J Musculoskelet Neuronal Interact; 2009; 9(1):53-60. PubMed ID: 19240369
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2).
Maegawa N; Kawamura K; Hirose M; Yajima H; Takakura Y; Ohgushi H
J Tissue Eng Regen Med; 2007; 1(4):306-13. PubMed ID: 18038421
[TBL] [Abstract][Full Text] [Related]
16. The effect of combined application of TGFbeta-1, BMP-2, and COLLOSS E on the development of bone marrow derived osteoblast-like cells in vitro.
van der Zande M; Walboomers XF; Briest A; Springer M; Alava JI; Jansen JA
J Biomed Mater Res A; 2008 Sep; 86(3):788-95. PubMed ID: 18041723
[TBL] [Abstract][Full Text] [Related]
17. DRAGON, a GPI-anchored membrane protein, inhibits BMP signaling in C2C12 myoblasts.
Kanomata K; Kokabu S; Nojima J; Fukuda T; Katagiri T
Genes Cells; 2009 Jun; 14(6):695-702. PubMed ID: 19422419
[TBL] [Abstract][Full Text] [Related]
18. The content of bone morphogenetic proteins in platelets varies greatly between different platelet donors.
Kalén A; Wahlström O; Linder CH; Magnusson P
Biochem Biophys Res Commun; 2008 Oct; 375(2):261-4. PubMed ID: 18706392
[TBL] [Abstract][Full Text] [Related]
19. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
[TBL] [Abstract][Full Text] [Related]
20. Naringin-induced bone morphogenetic protein-2 expression via PI3K, Akt, c-Fos/c-Jun and AP-1 pathway in osteoblasts.
Wu JB; Fong YC; Tsai HY; Chen YF; Tsuzuki M; Tang CH
Eur J Pharmacol; 2008 Jul; 588(2-3):333-41. PubMed ID: 18495116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
